Join PPD® Biotech for an engaging discussion on today’s opportunity-rich biotech financing landscape for Bay Area biotechnology companies. Our after-work networking reception will be followed by a panel discussion with interactive audience Q&A, moderated by John Carroll, editor of Endpoints News.
Marriott Waterfront San Francisco Airport
1800 Old Bayshore Highway, Burlingame, CA 94010
Thursday, 20 September 2018 | 5:30-8 p.m. PDT
This roundtable will feature some of the keenest minds in biotech and venture capital. Don’t miss this exciting opportunity to network, share expertise and learn from key players in the Bay Area biotech ecosystem.
The panelists include:
- Neil Kumar, Ph.D., Chief Executive Officer, BridgeBio Pharma
- Robert McDowell, Ph.D., Chief Scientific Officer, MyoKardia, Inc.
- Paul Scansaroli, Managing Director, Barclays Equity Capital Markets
- Sujal Shah, President and Chief Executive Officer, CymaBay Therapeutics, Inc.
- Sandy Zweifach, President and Chief Executive Officer, Nuvelution Pharma, Inc.
Please fill out the following form to RSVP